D-二聚体排除妊娠期静脉血栓栓塞症的系统评价与荟萃分析
该系统评价与荟萃分析纳入4项研究,评估D-二聚体阴性后不抗凝的妊娠女性3个月血栓栓塞率为1/312(0.32%;95%CI 0.06-1.83)。合并敏感度99.5%(95%CI 95.0-100.0;I²=0%),阴性预测值100%(95%CI 99.19-100.0;I²=0%)。结果表明在低/中度或不太可能验前概率下,D-二聚体可安全排除妊娠期VTE。
要点
- D-二聚体阴性后未抗凝的妊娠女性3个月血栓栓塞率为0.32%(95%CI 0.06-1.83)。
- 合并敏感度99.5%、阴性预测值100%,支持D-二聚体排除VTE。
- 适用条件为VTE患病率与低/中度或不太可能验前概率一致。
核心结论
- D-二聚体可在疑似VTE且验前概率为低/中度或不太可能的妊娠女性中安全排除VTE。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed和Embase至2021年6月第1周,最终纳入4项研究(3项前瞻性、1项回顾性)。
主要发现
- D-二聚体阴性后未抗凝的妊娠女性3个月血栓栓塞率为1/312(0.32%;95%CI 0.06-1.83)。
- 合并敏感度为99.5%(95%CI 95.0-100.0;I²=0%),阴性预测值为100%(95%CI 99.19-100.0;I²=0%)。
- VTE患病率为7.4%(95%CI 3.8-12;I²=83%),D-二聚体阳性率为34.2%(95%CI 15.9-55.23;I²=89%)。
临床怎么用
- 对疑似VTE且验前概率为低/中度或不太可能的妊娠女性,可依据D-二聚体阴性排除VTE。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The usefulness of D-dimer measurement to rule out venous thromboembolism (VTE) during pregnancy is debated. OBJECTIVES: We performed a systematic review and meta-analysis to investigate the safety of D-dimer to rule out acute VTE in pregnant women with suspected pulmonary embolism and/or deep vein thrombosis. METHODS: Two reviewers independently identified studies through PubMed and Embase until June 2021, week 1. We supplemented our search by manually reviewing reference lists of all retrieved articles, clinicalTrials.gov, and reference literature. Prospective or retrospective studies in which a formal diagnostic algorithm was used to evaluate the ability of D-dimer to rule out VTE during pregnancy were eligible. RESULTS: We identified 665 references through systematic database and additional search strategies; 45 studies were retrieved in full, of which four were included, after applying exclusion criteria. Three studies were prospective, and one had a retrospective design. The 3-month thromboembolic rate in pregnant women left untreated after a negative D-dimer was 1/312 (0.32%; 95% CI, 0.06-1.83). The pooled estimate values were 99.5% for sensitivity (95% CI, 95.0-100.0; I², 0%) and 100% for negative predictive value (95% CI, 99.19-100.0; I², 0%). The prevalence of VTE and the yield of D-dimer were 7.4% (95% CI, 3.8-12; I², 83%) and 34.2% (95% CI, 15.9-55.23; I², 89%) respectively. CONCLUSION: Our results suggest that D-dimer allows to safely rule out VTE in pregnant women with suspected VTE and a disease prevalence consistent with a low/intermediate or unlikely pretest probability.
引用
- Bellesini M, Robert-Ebadi H, Combescure C, et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J Thromb Haemost. 2021. PMID: 34161671. doi:10.1111/jth.15432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。